Malignant cardiac tumors: Diagnosis and treatment

Chiara Lestuzzi, Antonino De Paoli, Tanja Baresic, Gianmaria Miolo, Angela Buonadonna

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Primary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment require a multidisciplinary approach, and the cardiologist plays a central role both in the diagnosis and in the follow-up. The prognosis may be improved by a careful planning of surgery and by the use of multimodality treatment, including complementary chemotherapy and radiation therapy. A strict follow-up must be planned even after apparently complete cure.

Original languageEnglish
Pages (from-to)485-500
Number of pages16
JournalFuture Cardiology
Volume11
Issue number4
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Heart Neoplasms
Complementary Therapies
Sarcoma
Non-Hodgkin's Lymphoma
Radiotherapy
Drug Therapy
Therapeutics
Cardiologists

Keywords

  • Cardiac lymphoma
  • Cardiac malignancy
  • Cardiac radiotherapy
  • Cardiac sarcomas
  • Cardiac tumors
  • Chemotherapy
  • Malignant cardiac tumors
  • Non-Hodgkin lymphoma
  • Sarcoma
  • Surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Molecular Medicine

Cite this

Malignant cardiac tumors : Diagnosis and treatment. / Lestuzzi, Chiara; De Paoli, Antonino; Baresic, Tanja; Miolo, Gianmaria; Buonadonna, Angela.

In: Future Cardiology, Vol. 11, No. 4, 01.07.2015, p. 485-500.

Research output: Contribution to journalArticle

@article{63d431d7144d44dbbcefc4ed9d5be2b3,
title = "Malignant cardiac tumors: Diagnosis and treatment",
abstract = "Primary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment require a multidisciplinary approach, and the cardiologist plays a central role both in the diagnosis and in the follow-up. The prognosis may be improved by a careful planning of surgery and by the use of multimodality treatment, including complementary chemotherapy and radiation therapy. A strict follow-up must be planned even after apparently complete cure.",
keywords = "Cardiac lymphoma, Cardiac malignancy, Cardiac radiotherapy, Cardiac sarcomas, Cardiac tumors, Chemotherapy, Malignant cardiac tumors, Non-Hodgkin lymphoma, Sarcoma, Surgery",
author = "Chiara Lestuzzi and {De Paoli}, Antonino and Tanja Baresic and Gianmaria Miolo and Angela Buonadonna",
year = "2015",
month = "7",
day = "1",
doi = "10.2217/fca.15.10",
language = "English",
volume = "11",
pages = "485--500",
journal = "Future Cardiology",
issn = "1479-6678",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Malignant cardiac tumors

T2 - Diagnosis and treatment

AU - Lestuzzi, Chiara

AU - De Paoli, Antonino

AU - Baresic, Tanja

AU - Miolo, Gianmaria

AU - Buonadonna, Angela

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Primary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment require a multidisciplinary approach, and the cardiologist plays a central role both in the diagnosis and in the follow-up. The prognosis may be improved by a careful planning of surgery and by the use of multimodality treatment, including complementary chemotherapy and radiation therapy. A strict follow-up must be planned even after apparently complete cure.

AB - Primary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment require a multidisciplinary approach, and the cardiologist plays a central role both in the diagnosis and in the follow-up. The prognosis may be improved by a careful planning of surgery and by the use of multimodality treatment, including complementary chemotherapy and radiation therapy. A strict follow-up must be planned even after apparently complete cure.

KW - Cardiac lymphoma

KW - Cardiac malignancy

KW - Cardiac radiotherapy

KW - Cardiac sarcomas

KW - Cardiac tumors

KW - Chemotherapy

KW - Malignant cardiac tumors

KW - Non-Hodgkin lymphoma

KW - Sarcoma

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84939420160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939420160&partnerID=8YFLogxK

U2 - 10.2217/fca.15.10

DO - 10.2217/fca.15.10

M3 - Article

C2 - 26235817

AN - SCOPUS:84939420160

VL - 11

SP - 485

EP - 500

JO - Future Cardiology

JF - Future Cardiology

SN - 1479-6678

IS - 4

ER -